2/5/2026Fosun Secures Priority Review in China for Luvometinib's New Indicatio...

2/5/2026Ascentage Secures China IND Clearance for Next-Gen BTK Degrader APG-32...

2/4/2026Innovent Advances IL-15 Antibody IBI3013 Into Clinical Trials for Viti...

2/4/2026China Clears BeBetter Med Dual-Target siRNA Therapy for Combined Hyper...

2/4/2026Chia Tai Tianqing's Anlotinib New Indication Application Rejected

2/4/2026Almirall's Seysara Approved in China for Moderate-to-Severe Acne

2/4/2026Bayer's Nubeqa Gains Third Approval in China for Advanced Prostate Can...

2/4/2026CMS Gets Green Light from NMPA to Launch Trials for Novel Kidney Disea...

2/3/2026HSG Completes Global Acquisition of Avelox and Launches Anti-Infective...

2/3/2026Siran Bio Advances Global Clinical Development of ALK7 siRNA SA030

2/3/2026Hengrui's Camrelizumab Combo Accepted by FDA for First-Line Liver Canc...

2/3/2026Zhiben Wins China IND Approval for AR Molecular Glue Degrader ZB-002 i...

1/30/2026CSPC's SYS6055 Becomes First In Vivo CAR-T Therapy Approved for Clinic...

1/30/2026CMS Secures NMPA Approval for Opzelura in Non-Segmental Vitiligo

1/30/2026Sciwind Receives China Approval for Ecnoglutide Injection in Type 2 Di...

1/29/2026Phase III Trial Shows Anbenitamab Significantly Improves Survival in H...

1/29/2026Sciwind Reports Positive Phase III Results for Ecnoglutide in T2DM

1/29/2026The United Labs Secures U.S. FDA IND Clearance for Novel β-Lactamase ...

1/29/2026Novartis Wins Expanded China Approval for Leqvio

1/27/2026CTTQ's TQA3605 Shows Promising Phase 2 Results in Chronic HBV Treatmen...

1/26/2026Visen's Lonapegsomatropin Approved in China for Pediatric GHD

1/26/2026BMS Accelerates Global Development of PD-L1/VEGF Bispecific After Biot...

1/26/2026Huahui Wins Conditional Approval in China for First Hepatitis D Therap...

1/23/2026Mabwell Advances CDH17 ADC Program with First U.S. Patient Dosed

1/23/2026Insilicon Secures FDA IND Clearance for Oral NLRP3 Inhibitor ISM8969

1/22/2026Henlius Gains NMPA Green Light for Phase 1b/2 Trial of HLX701

1/22/2026Genmab Halts Development of Three China-Originated Oncology Assets fro...

1/22/2026Daiichi Sankyo Wins New China Approval for Enhertu

1/22/2026AbbVie Secures China Approval for Skyrizi in Ulcerative Colitis

1/22/2026Juncell Unveils Phase I TIL Data for Advanced NSCLC as IPO Push Accele...

Page:1/22 Total number of articles:642: [First][<<] [1] [2] [3] [4] [5] [>>] [End]